packageConcizumab

concizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Concizumab, a monoclonal antibody, is used to treat hemophilia A and hemophilia B. It is authorised in the European Union and is also being investigated for further uses.

Summary written by glm-5.3-flash from Wikidata Q104153457 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:concizumab
ATC codes:B02BX10
DrugBank:DB12820
Wikidata:Q104153457

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown